Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $274.62 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $93.43 | 4 | $0 (2024) |
| Lilly USA, LLC | $39.60 | 2 | $0 (2024) |
| Novo Nordisk Inc | $38.59 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $32.52 | 2 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $23.33 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $16.76 | 1 | $0 (2024) |
| Amgen Inc. | $15.31 | 1 | $0 (2023) |
| Dexcom, Inc. | $15.08 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $119.06 | 5 | ABBVIE INC. ($66.28) |
| 2023 | $155.56 | 9 | Novo Nordisk Inc ($38.59) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: VACCINE | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Diabetes | ||||||
| 12/13/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Endocrinology | ||||||
| 10/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Diabetes | ||||||
| 08/08/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Diabetes | ||||||
| 08/02/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Bone Health | ||||||
| 07/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 07/07/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Diabetes | ||||||
| 06/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 4 | 150 | 162 | $27,440 | $7,832 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 78 | 85 | $12,495 | $3,540 | 28.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 41 | 46 | $9,890 | $2,350 | 23.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 13 | 13 | $4,875 | $1,902 | 39.0% |
| 81003 | Automated urinalysis test | Office | 2020 | 18 | 18 | $180.00 | $40.30 | 22.4% |
About Lyndy Croft
Lyndy Croft is a Emergency healthcare provider based in Hiram, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2018. The National Provider Identifier (NPI) number assigned to this provider is 1891283115.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lyndy Croft has received a total of $274.62 in payments from pharmaceutical and medical device companies, with $119.06 received in 2024. These payments were reported across 14 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($274.62).
As a Medicare-enrolled provider, Croft has provided services to 150 Medicare beneficiaries, totaling 162 services with total Medicare billing of $7,832. Data is available for 1 year (2020–2020), covering 4 distinct procedure/service records.
Practice Information
- Specialty Emergency
- Other Specialties Family
- Location Hiram, GA
- Active Since 04/23/2018
- Last Updated 09/08/2020
- Taxonomy Code 163WE0003X
- Entity Type Individual
- NPI Number 1891283115
Products in Payments
- MOUNJARO (Drug) $39.60
- UBRELVY (Drug) $33.23
- QULIPTA (Drug) $33.05
- VRAYLAR (Drug) $27.15
- GVOKE HYPOPEN (Drug) $23.33
- Rybelsus (Drug) $20.06
- Ozempic (Drug) $18.53
- TRELEGY ELLIPTA (Drug) $17.00
- GARDASIL (Biological) $16.76
- AREXVY (Drug) $15.52
- EVENITY (Biological) $15.31
- Dexcom G6 Transmitter (Medical Supply) $15.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.